Chagas C-205 series (DNDi/Epichem/Monash University/Griffiths University/BIOASTER/CDCO/Eurofins/London School of Hygiene and Tropical Medicine/WuXi AppTech/AbbVie/)

N/A

Report date: 2025/03/14 16:17:27

NME

Base Information

Drug NameChagas C-205 series (DNDi/Epichem/Monash University/Griffiths University/BIOASTER/CDCO/Eurofins/London School of Hygiene and Tropical Medicine/WuXi AppTech/AbbVie/)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsChagas Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDrugs For Neglected Diseases Initiative

China Registration ClassN/A

Develop Information

Active CompaniesEpichem Group Ltd Centre for Drug Candidate Optimisation Griffith University +[10]

Inactive CompaniesN/A

Active IndicationsChagas Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A